MediClin AG (XTER:MED) Other Current Payables: €-0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:MED MediClin AG XTER:MED
79 GF Score
Price €4.16
GF Value €3.04
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is MediClin AG Other Current Payables?

MediClin AG XTER:MED +0.97% 79 Other Current Payables is €-0.0 Mil as of Mar. 2026. GuruFocus rates XTER:MED with a GF Score™ of 79/100 and a GF Value™ of €3.04 (Significantly Overvalued). The stock has 5 warning signs investors should review.

MediClin AG's Other Current Payables for the quarter that ended in Mar. 2026 was €-0.0 Mil.

MediClin AG's quarterly Other Current Payables declined from Sep. 2025 (€84.8 Mil) to Dec. 2025 (€33.5 Mil) and declined from Dec. 2025 (€33.5 Mil) to Mar. 2026 (€-0.0 Mil).

MediClin AG's annual Other Current Payables increased from Dec. 2023 (€25.4 Mil) to Dec. 2024 (€43.0 Mil) but then declined from Dec. 2024 (€43.0 Mil) to Dec. 2025 (€33.5 Mil).

MediClin AG Other Current Payables Related Terms

MediClin AG Other Current Payables Historical Data

* Premium members only.

The historical data trend for MediClin AG's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediClin AG Other Current Payables Chart

MediClin AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 28.01 25.40 43.03 33.45

MediClin AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.79 89.89 84.78 33.45 -0.00
XTER:MED
79GF Score
MediClin AG XTER:MED
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediClin AG Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €-0.0 Mil mean?
MediClin AG (XTER:MED) has a Other Current Payables of €-0.0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on MediClin AG and its competitors.
Is MediClin AG's Other Current Payables too high?
MediClin AG's current Other Current Payables is €-0.0 Mil. Overall, MediClin AG has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediClin AG's Other Current Payables compare to HCA and THC?
MediClin AG's Other Current Payables of €-0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Healthcare Providers & Services company?
A good Other Current Payables depends on the Healthcare Providers & Services industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on MediClin AG and its competitors. MediClin AG's current Other Current Payables is €-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediClin AG stock overvalued right now?
Based on GuruFocus' analysis, MediClin AG (XTER:MED) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.04, compared to a current price of €4.16 — trading 36.8% above its estimated fair value. The current Other Current Payables is €-0.0 Mil. MediClin AG's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For MediClin AG (XTER:MED), the current Other Current Payables is €-0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MediClin AG (XTER:MED) Overvalued in 2026?

Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued. The current stock price of €4.16 is trading 36.8% above its estimated GF Value™ of €3.04. GuruFocus considers MediClin AG to be Significantly Overvalued.

Key valuation signals for XTER:MED:

  • Other Current Payables: €-0.0 Mil
  • GF Value™: €3.04 vs. price of €4.16 (36.8% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the XTER:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MediClin AG Business Description

Other Exchanges 0NDG:UK
Address Okenstrasse 27, Offenburg, BW, DEU, 77652
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
79GF Score

Get the complete analysis for XTER:MED

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.16
Price
€3.04
GF Value